RESPONSE ONCOLOGY INC 

$0.000001
2
+$0.00+0% Tuesday 15:30

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
12.18
市盈率
0
股息率
-
股息
-

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。
福泰製藥 (Vertex Pharmaceuticals)
VRTX
市值138.42B
Vertex Pharmaceuticals专注于开发和推广癌症和其他严重疾病的疗法,在肿瘤学市场直接竞争。
百时美施贵宝 (Bristol-Myers Squibb)
BMY
市值136.49B
Bristol-Myers Squibb是肿瘤领域的重要参与者,为各种癌症开发了许多药物,与Response Oncology的市场重叠。
默沙东 (Merck)
MRK
市值370.89B
默克以在癌症治疗领域拥有强大的产品组合而闻名,包括与 Response Oncology 的产品竞争的免疫疗法药物。
輝瑞 (Pfizer)
PFE
市值162.16B
辉瑞拥有广泛的癌症治疗产品,包括乳腺癌和肺癌疗法,与 Response Oncology 的癌症护理解决方案竞争。
Novartis
NVS
市值304.1B
诺华提供靶向癌症疗法,在肿瘤学市场具有重要地位,因此是直接竞争对手。
安进 (AMGEN)
AMGN
市值236.38B
安进专注于人类治疗,包括癌症治疗,在肿瘤治疗市场上与Response Oncology竞争。
吉利德科學公司 (Gilead Sciences)
GILD
市值187.23B
吉利德科学以其在医学领域的创新而闻名,也越来越专注于肿瘤学,与Response Oncology的癌症治疗展开竞争。
雷傑納隆製藥 (Regeneron Pharmaceuticals)
REGN
市值85.22B
Regeneron Pharmaceuticals参与开发和推广治疗癌症的产品,直接与Response Oncology竞争。
Astrazeneca
AZN
市值252.33B
阿斯利康在肿瘤学领域拥有强大的产品管道,包括治疗各种癌症的疗法,与 Response Oncology 的产品竞争。
強生公司 (Johnson & Johnson)
JNJ
市值663.28B
强生公司通过其制药部门,为多种癌症开发治疗方法,在与Response Oncology相同领域竞争。

关于

Medical/Nursing Services
Health Services
Health Care and Social Assistance
Offices of Physicians (except Mental Health Specialists)
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Show more...
首席执行官
员工
10
国家
美国

上市

0 Comments

分享你的想法

FAQ

RESPONSE ONCOLOGY INC 今天的股价是多少?
ROIX 当前价格为 $0.00 USD,过去 24 小时上涨了 +0%。在图表上更密切关注 RESPONSE ONCOLOGY INC 股价表现。
RESPONSE ONCOLOGY INC 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 OTC MARKETS 交易所,RESPONSE ONCOLOGY INC 的股票以代码 ROIX 进行交易。
RESPONSE ONCOLOGY INC 的市值是多少?
今天 RESPONSE ONCOLOGY INC 的市值为 12.18
RESPONSE ONCOLOGY INC 有多少名员工?
截至九月 09, 2026,公司共有10名员工。
RESPONSE ONCOLOGY INC 属于哪个行业?
RESPONSE ONCOLOGY INC从事于健康与养生行业。
RESPONSE ONCOLOGY INC 何时完成拆股?
RESPONSE ONCOLOGY INC 最近没有进行任何拆股。